Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Stromag Provides Complete Powertrain Package For ZAUGG Snow Blowers

https://www.altramotion.com/en/newsroom/2021/12/stromag-provides-complete-powertrain-package-for-zaugg

byBenzinga Newsdesk

December 20, 2021

1 minute read

https://www.altramotion.com/en/newsroom/2021/12/stromag-provides-complete-powertrain-package-for-zaugg

Ayala Pharma Offers Key Business Objectives For 2022

By Benzinga Newsdesk

January 4, 9:27 AM

-- Data read-outs expected on AL102 in desmoid tumors and AL101 in ACC and TNBC -- REHOVOT, Israel and WILMINGTON, Del., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA), a

AYLA

Piper Sandler Maintains Overweight on Paycom Software, Raises Price Target to $472

By Benzinga Newsdesk

August 4, 4:57 AM

Piper Sandler analyst Arvind Ramnani maintains Paycom Software (NYSE:PAYC) with a Overweight and raises the price target from $417 to $472.

PAYC

Deutsche Bank Upgrades SL Green Realty to Buy, Raises Price Target to $82

By Benzinga Newsdesk

January 3, 7:34 AM

Deutsche Bank analyst Derek Johnston upgrades SL Green Realty (NYSE:SLG) from Hold to Buy and raises the price target from $77 to $82.

SLG

FDA
News

Candel Therapeutics Announces Presentations Of Key Clinical Data At AdMeTech And European Association Of Neuro-Oncology Conferences In September 2021

By Benzinga Newsdesk

September 9, 8:26 AM

Candel Therapeutics, Inc. (NASDAQ:CADL), today announced upcoming presentations of clinical data supporting continued clinical advancement of its prostate cancer and brain cancer programs at the following medical

CADL

Stromag Provides Complete Powertrain Package For ZAUGG Snow Blowers

Related Posts

Ayala Pharma Offers Key Business Objectives For 2022

Piper Sandler Maintains Overweight on Paycom Software, Raises Price Target to $472

Deutsche Bank Upgrades SL Green Realty to Buy, Raises Price Target to $82

Candel Therapeutics Announces Presentations Of Key Clinical Data At AdMeTech And European Association Of Neuro-Oncology Conferences In September 2021